Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03927105
Title Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Big Ten Cancer Research Consortium
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Unviersity of Wisconsin Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from for the field